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Abstract
Background. Assessing renal biopsies from patients
with lupus nephritis (LN) is a difficult task and it is
subject to interobserver variability. In this study the
interobserver agreement amongst five nephropatholo-
gists was analysed.
Methods. Five specialized nephropathologists scored
126 biopsies, comprising 87 first and 39 repeat biopsies
from 87 patients with biopsy-proven proliferative LN,
included in a randomized controlled trial. The
interobserver agreement [expressed as intraclass corre-
lation coefficients (ICC)] of the scored histopathologi-
cal items was calculated. Also, the WHO1995 and ISN/
RPS2003 classification systems for LN were compared,
with extra attention being given to the comparison
between patients with diffuse proliferative LN with
either segmental (IV-S) or global (IV-G) lesions.
Results. There was a wide range of agreement. A good
interobserver agreement (ICC> 0.6) was present in
15%, and a moderate interobserver agreement (ICC
0.4–0.6) in 31% of the scored items. The activity index
for LN showed a good (ICC 0.716) and the chronicity
index a moderate (ICC 0.494) interobserver agreement.
Both classification systems showed low agreement,
although consensus was easily reached. Patients
classified as IV-S (n¼ 15) had more favorable clinical
parameters at study entry than those with class IV-G
(n¼ 57). Although suggested by others, we found no
differences in outcome between these two subclasses.
Conclusions. This study shows that, although defini-
tions were agreed upon beforehand, even specialized
on nephropathologists have difficulties with scoring
histopathological characteristics of LN, particularly
with SLE the classification systems.
Keywords: agreement; kidney biopsy; lupus nephritis;
observer; systemic lupus erythematosus
Introduction
Systemic lupus erythematosus (SLE) is an autoimmune
disease in which virtually any organ can be affected [1].
Involvement of the kidney occurs frequently [2] and the
morphological changes observed in the kidney show
a great diversity [3]. Attempts have been made to
categorize the morphological changes in order to
recognize certain patterns, with the aim of providing
better guidelines for therapy and prognosis. Until the
beginning of this century, one of the WHO classifica-
tion systems for lupus nephritis (LN) was used, the
latest being the WHO1995 classification [3]. In 2003,
the classification for LN was redefined by the
International Society of Nephrology/Renal Pathology
Society (ISN/RPS) [4] in order to allow better
standardization of renal biopsies in lupus patients
than before [4,5]; in particular as it separates segmental
and global lesions. The importance of the latter was
suggested by Najafi et al. [6] in 2001. Patients with
diffuse proliferative LN and segmental lesions (n¼ 24)
were more likely to reach end-stage renal disease than
patients with diffuse proliferative LN and global
lesions (n¼ 35), although the number of patients
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entering remission and developing a renal flare was not
different.
In a search for a less toxic alternative for cyclophos-
phamide pulse therapy, the first Dutch LN
study started in 1995. In this study, 87 patients
with biopsy-proven proliferative LN were randomized
to either cyclophosphamide pulse therapy, or to
azathioprine combined with methylprednisolone
pulses [7]. After 2 years a repeat renal biopsy was
performed in 39 participants.
In order to evaluate the histomorphological lesions
of these biopsies in detail, a standardized scoring form
was developed. Here we report the interobserver
agreement among five specialized nephropathologists.
We also compare the WHO1995 classification with the
ISN/RPS2003 classification for LN.
Subjects and methods
Patient selection
From September 1995 until September 2001, 87 patients with
biopsy-proven proliferative LN were included in the first
Dutch LN study [7]. In this randomized controlled trial,
patients were treated with either azathioprine combined with
methylprednisolone and prednisone, or cyclophosphamide
pulse therapy with prednisone for 2 years. After 2 years,
this regimen was followed by long-term azathioprine and
prednisone. All patients were followed regularly, and clinical
and laboratory parameters were collected according to the
study protocol [7].
Renal biopsy
All biopsies were performed and processed locally. Before
randomization, all 87 inclusion biopsies were reviewed and
classified by at least one of three experienced nephropathol-
ogists according to the WHO1995 criteria for LN [3].
The activity index (AI) and chronicity index (CI) were
calculated for each specimen as described previously [8], with
maximum scores of 24 for the AI and 12 for the CI. After 2
years, all available patients were asked to have a repeat renal
biopsy performed for study purposes only. It was agreed that
findings in these biopsies would be anonymized and not used
for therapeutic decisions. The ethics committees of all
participating hospitals approved this pathology study,
and it was conducted according to the Declaration of
Helsinki. After informed consent, 41 patients underwent a
repeat renal biopsy. For this study silver-stained slides
(with HE-background), and for some items PAS slides,
were used.
Scoring procedure
Scoring form. Histological characteristics described in LN,
together with its definitions, were gathered from the
literature. In three consensus meetings with three specialized
nephropathologists, the list of items was reduced and a
concept scoring form was made. In a pilot study, 10 biopsies
were scored to solve discrepancies and problems. In a
consensus meeting, these discrepancies were discussed and
the scoring form was adjusted. In another consensus meeting,
the scoring form was again discussed and revised with five
different, experienced nephropathologists (I.B., S.F., E.S.,
C.P., R.G.) and a specialized nephropathologist from abroad
(Dr G. S. Hill, Hoˆpital Europeen Georges Pompidou, Paris,
France). With the final version and after collecting the slides
at a central office, three scoring sessions followed. Each
biopsy was scored by three of five nephropathologists.
Item selection and definitions. The first pathologist
marked the section with the most glomeruli and this slide
was subsequently used for the scoring procedure. For almost
all assessments, silver-stained slides were used (exceptions
were predefined). Scoring the biopsy was divided into several
sections: glomerular, tubular, interstitial and vascular.
For definitions see our previous publication [9]. For each
glomerulus, the presence of a variety of histopathological
items was counted. After having scored the section, the
nephropathologist was asked to give an opinion on the
overall quality of the biopsy: either poor, reasonable or
excellent. The quality was evaluated on both the quality of
the staining and the quality of the material.
The assessment was completed by filling out the
WHO1995 and ISN/RPS2003 classification and activity
and chronicity indices for LN [3,4,8]. For these aspects of
the assessment, the definitions belonging to the classification
systems and the activity and chronicity indices were used.
To simplify the comparisons between the two classification
methods, membranous features were mentioned as ‘þV’.
After all scoring sessions were finished, the discrepancies in
classification were discussed and a final joint judgement was
made, during three consensus meetings.
Statistics
All data were analysed by using SPSS 12.0.1 software.
All continuous glomerular variables were expressed as
the percentage of the total number of non-sclerotic and
non-ischemic glomeruli scored in the section.
Intraclass correlation coefficients (ICC) were used to
evaluate interobserver readings for the entire set of
slides [10]. The ICC is an index of concordance that
indicates the degree of agreement beyond that expected
by chance alone, and is appropriate when assessing
agreement between two or more raters. It is expressed
in a score ranging between 0 and 1:0 indicating
agreement by chance and 1 total agreement. In general,
values higher than 0.8 are considered as excellent,
values between 0.6 and 0.8 as good, values between 0.4
and 0.6 as moderate, and values below 0.4 as poor
concordance. The ICCs of both continuous, binominal
and ordinal variables can be computed, which also
takes into account the ranking order of the variables.
The ICC was favored over the Cohen Kappa value
since each of the five observers scored only 3/5 of the
biopsies. The scoring of the biopsies was organized in
such a way that an overlap of at least one-third of the
slides existed between two nephropathologists.
To account for possible systematic differences
between nephropathologists, the nephropathologists
were added as ‘random effects’. In doing so, the found
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ICCs are comparable with the weighted Kappa.
Although the classification systems for LN are not
actual ordinal variables, for this analysis they were
regarded to be ordinal. Comparing the classes without
their subcategories would be too rough.
For the descriptive parameters and the comparisons,
only those histopathological characteristics with an
ICC> 0.4 were used. The mean value of the scores of
the three pathologists who scored the biopsy was
taken. Non-parametric tests were used for the compar-
ison between patient subgroups. A P-value <0.05 was
regarded statistically significant.
Results
Biopsies
In total 128 renal biopsies were performed in 87
patients. All patients underwent a biopsy at study
entry. Forty one patients agreed to undergo a repeat
biopsy after two years of therapy. Of these 41 repeat
biopsies, two did not contain glomeruli and were not
included, leaving 126 biopsies for scoring. Overall, the
quality of the preparation of the biopsies was good:
55% were judged as excellent and 28% as reasonable.
However, in 17% of the biopsies either the staining or
cutting quality was judged as poor. A total of nine
biopsies could not be classified. Reasons were: six or
less glomeruli (n¼ 7; five repeat biopsies and two taken
at study entry), or poor quality (n¼ 2, both repeat
biopsies).
Interobserver agreement
The analyses were performed for all 126 biopsies. A
wide range of agreement for the diverse characteristics
was found. Good or excellent concordance (ICC> 0.6)
was present in 15% of all 54 scored characteristics.
Agreement was moderate (ICC 0.4–06) in 31% and low
(ICC< 0.4) in 54% of all scored characteristics.
The ICCs did not improve if the analyses were done
after exclusion of biopsies with six or less glomeruli or
biopsies of poor quality. The observed ICCs also did
not change if only the biopsies taken at study entry
were analysed. In Table 1 the variables for which
excellent, good or moderate agreement existed are
listed.
Glomeruli. Excellent or good intraclass correlation
coefficients were found for the following items: total
number of glomeruli (ICC 0.950), completely sclerosed
glomeruli (0.821), endocapillary proliferation (0.646),
extracapillary proliferation (0.639) and spikes (0.629).
For several items a moderate ICC was found (Table 1).
Tubules and interstitium. Two tubular variables
(tubular atrophy and casts) were scored with moderate
agreement. Interstitial infiltrate and fibrosis showed
acceptable ICCs, while disagreement existed for
edema.
Vascular changes. Vascular changes were not observed
very often. Only for arterial fibrous intimal hyperplasia
and arterial thrombosis, acceptable agreement was
observed (ICC 0.461 and 0.421, respectively).
Activity and chronicity index. Good concordance was
present for the AI (ICC 0.716) and moderate con-
cordance for the CI (ICC 0.494).
WHO1995 classification and ISN/RPS2003
classification
Remarkably low ICCs (ICC< 0.2) were found for the
classification systems, using both the WHO1995 and
the ISN/RPS2003 classification. If for the WHO1995
classification the subclasses were excluded, and the
classes II, III, IV, V and VI were compared, the level of
agreement slightly improved (ICC improved from
0.108 to 0.368). And, if the classes were divided into
class II, III, IV-S, IV-G, V and VI (ISN/RPS2003
classification) the ICC increased from 0.182 to 0.414.
Table 2 shows how, after reaching consensus, all
biopsies were classified. Membranous features were
present in 6 (25%) and in 8 (10%) of the biopsies
classified as class III and IV, respectively.
Table 1. Interobserver agreement: items for which agreement was
excellent (ICC> 0.8), good (ICC 0.6–0.8) or moderate (ICC 0.4–0.6)
Item ICC
Glomerular
Total glomeruli 0.950
Completely sclerosed glomeruli 0.821
Endocapillary proliferationa 0.646
Extracapillary proliferationa 0.639
Spikesa 0.629
Synechiaa 0.522
Wire loopsa 0.498
Karyorrhexisa 0.482
Ischemic glomerulia 0.455
Loop necrosisa 0.439
Tubulo-interstitial
Interstitial infiltrate 0.514
Tubular atrophy 0.511
Casts 0.458
Interstitial fibrosis 0.418
Indices
Activity index 0.716
Chronicity index 0.494
ICC, intraclass correlation coefficient. For the following items a
poor interobserver agreement (ICC< 0.4) was found: double
contours, normal glomeruli, mesangiolysis, mesangial proliferation,
glomerular infiltration (both mononuclear and polynuclear), mesan-
gial sclerosis (both segmental and global), lumenal macrophages,
tubular necrosis, interstitial edema, WHO1995 classification, ISN/
RPS2003 classification, and some subscores of the activity and
chronicity indices: cellular proliferation, fibrinoid necrosis/karyor-
rhexis, leukocyte infiltration, tubulointerstitial mononuclear infiltra-
tion, glomerular sclerosis, fibrous crescents, interstitial fibrosis.
The vascular items were not present often.
aPercentage of glomeruli affected by the characteristic that was
scored (expressed as percentage of non-sclerotic and non-ischemic
glomeruli).
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Segmental vs global diffuse proliferative LN
In view of the assumed prognostic importance, patients
with ISN/RPS2003 class IV-S and IV-G were assessed
separately. At study entry, 15 biopsies were classified
as class IV-S and 57 as class IV-G. The clinical
characteristics are summarized in Table 3. Patients
with segmental lesions had more favorable character-
istics: their renal function was better, hypertension was
less often present, and complement values and
hemoglobin were higher. A number of outcome
parameters were not different between the two
groups. Actually, more patients had doubling of
serum creatinine in the IV-G group (n¼ 5) than in
the IV-S group (n¼ 0), after a median follow-up of 77
months (interquartile range (IQR) 54–96), but the
differences were not statistically significant. Log rank
analysis of (time to) partial and complete remission did
not show differences between the two groups. Not
unexpectedly, more endocapillary proliferation and
higher scores for wire loops were present in the biopsies
categorized as class IV-G. Also, the total activity index
was lower in class IV-S (7.7 vs 9.7), but this difference
was not significant (Table 4 gives the histological
characteristics).
To allow a comparison between the ISN/RPS2003
and the WHO1995 classification, the clinical and
Table 2. WHO1995 and ISN/RPS2003 classification in 117 biopsies
(85 biopsies at study entry and 32 repeat biopsies)
WHO1995 n ISN/RPS2003 n
I 0
IIa 11 II 10
IIb 3 II 1
IIIa 5 III-A 5
IIIb 7 III-A/C 7
IIIc 12 III-C 12
IVa 4 IV-G-A 4
IVb 13
IV-S-A 1
IV-S-A/C 1
IV-G-A 6
IV-G-A/C 5
IVc 56
IV-S-A/C 15
IV-G-A 2
IV-G-A/C 39
IVd 5
IV-S-C 2
IV-G-C 3
V 0 3
VI 1 VI 1
total 117
Three biopsies were classified as class II LN in the WHO1995
classification, but due to the presence of membranous features these
were classified as class V in the ISN/RPS2003 classification
Table 3. Clinical characteristics of 72 patients with class IV lupus nephritis at study entry and during follow-up.
IV-S IV-G IVa or IVb IVc or IVd
n¼ 15 n¼ 57 P n¼ 17 n¼ 55 P
Clinical characteristics
CY/AZA (n) 9/6 35/22 ns 7/10 37/18 ns
Age (year) 37 (28–47) 31 (24–41) ns 26 (21–34) 33 (24–44) 0.037
Female (n) (%) 12 (80) 50 (88) ns 12 (71) 50 (91) 0.034
Caucasian (n) (%) 12 (87) 40 (70) ns 12 (71) 41 (75) ns
Nephritis in past (n) (%) 3 (20) 12 (21) ns 1 (6) 14 (26) ns
Hypertension (n) (%) 4 (27) 35 (61) 0.017 8 (47) 31 (56) ns
Systolic blood pressure (mmHg) 140 (120–145) 140 (120–150) ns 140 (120–153) 140 (120–150) ns
Diastolic blood pressure (mmHg) 80 (70–90) 80 (80–90) ns 80 (78–98) 80 (80–90) ns
Disease duration (months) 2.5 (0.4–109) 22 (1–82) ns 2 (1–27) 22 (1–102) ns
SLEDAI 20 (14–26) 21 (16–24) ns 22 (17–27) 20 (14–24) ns
Laboratory parameters
Screat (mmol/l)a 95 (72–121) 112 (87–154) 0.039 98 (84–139) 115 (85–152) ns
Proteinuria (g/24 h) 3.5 (1.8–6.5) 4.2 (2.7–6.6) ns 3.9 (2.8–6.2) 4.1 (2.2–6.7) ns
Hemoglobin (mmol/l) 7.6 (7.0–8.3) 6.2 (5.6–7.2) 0.000 6.9 (5.6–7.6) 6.3 (5.6–7.5) ns
C3 (g/l) 0.54 (0.47–0.77) 0.43 (0.32–0.60) 0.012 0.45 (0.24–0.62) 0.49 (0.38–0.63) ns
C4 (g/l) 0.12 (0.10–0.22) 0.10 (0.07–0.12) 0.008 0.08 (0.07–0.14) 0.10 (0.08–0.14) ns
Anti-dsDNA (IU/ml) 141 (37–558) 166 (18–553) ns 342 (93–807) 124 (22–502) ns
Outcome parameters
Follow-up (months) 78 (63–95) 76 (54–95) ns 93 (54–107) 75 (54–88) ns
Screat 2 (n)(%)b 0 (0) 5 (9) ns 1 (6) 4 (7) ns
Failure/relapse (n)(%) 2 (13) 10 (18) ns 2 (12) 10 (18) ns
Complete remission (n)(%) 7 (53) 32 (56) ns 12 (71) 28 (51) ns
Partial remission (n)(%) 13 (87) 54 (94) ns 16 (94) 51 (93) ns
Screat at last follow-up (mmol/l) 86 (71–94) 79 (73–108) ns 81 (63–111) 79 (72–104) ns
Proteinuria at last follow-up (g/24 h) 0.5 (0.1–1.4) 0.2 (0.1–0.8) ns 0.1 (0.1–0.5) 0.3 (0.1–1.1) ns
IV-S, class IV-segmental; IV-G, class IV-global; CY, patients treated with cyclophosphamide pulses; AZA, patients treated with azathioprine
and methylprednisolone pulses; SLEDAI, SLE disease activity index; Screat, serum creatinine; C3, complement C3; C4, complement C4;
Screatx2, doubling of serum creatinine. Comparison of ISN/RPS2003 class IV-S and IV-G, and of WHO1995 class IVa/IVb and IVc/IVd.
Number and percentage, or median with interquartile range is given.
aTo convert serum creatinine to mg/dl divide by 88.4.
bPrimary study end point.
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histopathological characteristics were also evaluated
for patients with WHO1995 class IVa or IVb vs those
classified as class IVc or IVd (data are added to
Tables 3 and 4). We argued that class IVa and IVb
represent the biopsies with more acute lesions, while
IVc and IVd are more chronic forms of LN. Of the
15 patients classified as ISN/RPS2003 class IV-S, only
2 were categorized as WHO1995 class IVa or IVb and
13 as IVc or IVd. For the 57 patients classified as ISN/
RPS2003 class IV-G this was 15 and 42, respectively.
Discussion
This is the first time that the interobserver agreement
for many predefined histopathological characteristics
of LN was studied thoroughly, along with both the
WHO1995 and the ISN/RPS2003 classification for
LN. Previous studies have hinted on this subject, but
either did not incorporate classification data or used
the histological characteristics for (prognostic) regres-
sion analyses only. The present study was based on 126
renal biopsies of 87 patients with proliferative LN in
their initial biopsy, who were included in a randomized
controlled trial. We found a wide range of agreement,
not only for the diverse histological characteristics but
also for the WHO1995 and ISN/RPS2003 classifica-
tion, of which the latter was assumed to be easily
reproducible [5]. A good interobserver agreement was
present in only 15% of the 54 scored characteristics,
and moderate in 31%. The observation that if more
pathologists examine a biopsy, the disagreement will
increase, was described in many other pathology
studies [11,12], and is therefore not unique for LN.
However, since in lupus the variety of histological
abnormalities is huge as compared to other diseases,
the problem of variable interobserver agreement in
lupus will probably be larger. We can only speculate
about the reasons for the lack of agreement.
The agreement of the total score of AI and CI
appeared to be good to moderate (0.716 and 0.494,
respectively). This is in line with observations by others
[13].
During the scoring sessions and the consensus
meetings, we encountered several difficulties in inter-
preting the definitions and slides. Although definitions
for each item were agreed upon beforehand, the
nephropathologists may have interpreted some of
these definitions differently during the scoring
rounds. Most importantly, however, some of the
lesions seem to defy definition, of which we give a
number of examples in Figure 1.We were somewhat
hampered by the variable quality of the slides, caused
by the fact that the biopsies were taken, cut and stained
locally. Unfortunately, immunofluorescence slides
were not available for this study.
The disagreement on classification was striking: both
for the WHO1995 and ISN/RPS2003 classification low
ICCs were found (<0.2). Potential causes for these low
levels of agreement are: poor quality of the slides,
smaller biopsies, biopsies in which around half of the
glomeruli were affected, affected glomeruli with both
segmental and global lesions, and the presence of the
most prominent proliferative lesions in the glomeruli at
the edge of the slide. According to the definition of
total number of glomeruli, the latter had to be
disregarded, thereby hampering a proper classification.
No clinical data were given to the pathologists. One
could argue that disagreement over a class III or IV
LN is less cumbersome than disagreement over class II
or IV. Therefore, we categorized the biopsies in
proliferative vs non-proliferative LN. This did not
reveal better ICCs (ICC for WHO1995 was 0.312 and
for ISN/RPS2003 was 0.251). So the discrepancies in
classification cannot be explained by disagreement
Table 4. Histopathological characteristics of 72 patients with class IV lupus nephritis at study entry
IV-S IV-G IVa or IVb IVc or IVd
n¼ 15 n¼ 57 P n¼ 17 n¼ 55 P
Active lesions
Endocapillary proliferation 50 (37–77) 80 (67–96) 0.002 86 (68–93) 74 (52–92) ns
Extracapillary proliferationa 21 (5–34) 12 (2–31) ns 33 (13–41) 10 (2–28) 0.020
Wire loop score 25% (n) (%) 1 (7) 27 (47) 0.004 8 (47) 20 (36) ns
Activity index
Total score 7.7 (5.3–11.7) 9.7 (7.3–12.5) ns 10.7 (9.2–13.0) 9.3 (7.0–11.0) 0.036
Score 10 (n) (%) 5 (33) 28 (49) ns 12 (71) 21 (38) 0.019
Chronic lesions
Completely sclerosed glomeruli 0 (0–5) 5 (0–9) ns 0 (0–1) 5 (0–11) 0.002
Synechia 27 (7–38) 16 (6–28) ns 10 (0–14) 23 (9–38) 0.01
Tubular atrophy score 25% (n) (%) 1 (7) 6 (11) ns 0 (0) 7 (13) ns
Interstitial fibrosis score 25% (n) (%) 1 (7) 3 (5) ns 0 (0) 4 (7) ns
Chronicity index
Total score 2.3 (1.7–3.3) 2.7 (20–3.7) ns 2.0 (1.3–2.7) 3.0 (2.0–3.7) 0.000
Score 4 (n) (%) 1 (7) 8 (14) ns 0 (0) 9 (16) ns
Comparison of ISN/RPS2003 class IV-S and IV-G, and comparison of WHO1995 class IVa/IVb and IVc/IVd. Median with interquartile
range, or number and percentage are is given.
aFibrous crescents are chronic lesions, while cellular crescents are active lesions. Fibrous crescents were scored rarely.
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Fig.1. Several examples of histomorphological characteristics, which might explain why a low interobserver agreement was found.
Furthermore, since the ISN/RPS2003 classification makes an explicit distinction between segmental and global lesions, we would like to show
you how difficult it can sometimes be to make this distinction. Considerations/answers are given in parentheses following the questions. (A) Is
this a normal glomerulus? (This is clearly not a normal glomerulus because it shows signs of ischemia, namely wrinkling of GBM and
irregular Bowman’s capsule. However, it does not contain lupus-related lesions. In counting glomeruli with and without lupus-related lesions,
for instance, to make a decision on a class III or class IV, this glomerulus would be on the ‘normal’ side, and was categorized as such on the
scoring form.) (B) Glomerulus with mesangial changes, but is there endocapillary proliferation as well? (Next to mesangial changes this
glomerulus shows chronic lesions, namely doubling of GBM and ischemia. However, in a number of capillary loops, endothelial cells are
prominently present. However, leucocytes are absent and obliteration of capillary loops due to proliferation hardly occurs. Three out of five
pathologists scored this as segmental endocapillary proliferation. However, the other two scored it as global endocapillary proliferation. It is
certainly a case of A/C.) (C) Glomerulus with extensive mesangial proliferation, but is there a component of endocapillary proliferation
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regarding focal or diffuse LN. Finally, for a correct
classification, a minimum number of ten glomeruli is
required [4]. In several cases, our classification was
made on less than ten glomeruli. However, this did not
explain the low interobserver agreement, since ICCs
did not change if the data were analysed for biopsies
with ten or more glomeruli only. Strikingly, we found
that during the consensus meetings, consensus was
often reached without difficulties.
Reports on the interobserver agreement of the
WHO1995 or ISN/RPS2003 classification are scarce
[14,15]. In most studies on LN only one nephropathol-
ogist classified the biopsies [16,17], or two nephro-
pathologists classified the biopsies in consensus
[6,18,19]. An exception is a report on the ISN/
RPS2003 classification which described 60 Japanese
patients with LN [14]. The consensus between two
pathologists for the ISN/RPS2003 and WHO1995
classification was 98 and 83%, respectively. Another
report showed that the consensus between two
pathologists who studied 420 biopsies, was better for
the ISN/RPS2003 classification than for the WHO1995
classification (96% vs 87%) [20]. Recently, Furness
et al. reported a study on interobserver variability
throughout the UK [15]. Twenty renal biopsies,
accompanied with clinical information and immuno-
fluorescence results, were sent to (untrained) patholo-
gists twice: the first time the pathologist was asked to
classify the biopsies according to the WHO1995
classification, the second according to the ISN/
RPS2003 classification. Calculated kappa values were
0.44 and 0.53 for the WHO1995 and ISN/RPS2003
classification, respectively. Disease activity (acute vs
chronic vs acute and chronic) was poorly agreed upon
( 0.33). They concluded that the ISN/RPS2003
classification is better reproducible. In our study, the
pathologists were unaware of clinical data.
The differences between class IV-S and IV-G may
become clinically important and lead to different
therapeutical guidelines. Our patients with IV-G had
more active disease and worse clinical parameters at
study entry. The outcome however was not different,
and none of the patients who were classified as IV-S
doubled their serum creatinine. One of the reasons that
we did not find differences in outcome could be due to
the fact that doubling of serum creatinine did not occur
often in our study (n¼ 5), after a reasonable follow-up.
Like others [14,21,22], we could not confirm the
findings by Najafi et al. [6] that IV-S had a worse
prognosis than IV-G. All these studies [14,21,22] also
found worse clinical and histopathological character-
istics in the IV-G patients. The chronicity index in our
population was lower than that in the original study
[6], and higher than that found in the French study
[22]. It is important to realize that the initial report
described an American population, while most of the
recent studies, including ours, were carried out on
either European or Asian patients. The comparison of
patients with WHO1995 class IVa or IVb with those
classified as class IVc or IVd revealed that IV-S and
IV-G present as different clinical entities, while IVa/b
and IVc/d are histopathologically different. Since for
the patients with class III LN an impaired renal
function was obligatory for inclusion in our trial, a
comparison between the patients with class IV-S and
IV-G with those with class III (n¼ 11) is not
meaningful.
In summary, although standardizing the assessment
of renal biopsies in LN is needed both for clinical and
research purposes, and although the new ISN/
RPS2003 classification seems to be of help, our study
shows that the detailed evaluation by specialized
nephropathologists shows variable degrees of agree-
ment with regard to various histopathological char-
acteristics. However, the detailed scoring system we
used is too laborious and unpractical for daily clinical
use.
Our results do not weaken the importance of the
classification for LN, but they raise the question
whether a further subclassification is meaningful.
Indeed, we did not find differences in the outcome
between the patients with class IV-S or IV-G lesions.
We believe that, until proven clinically useful, sub-
classifying diffuse proliferative LN into segmental or
global should be used for research purposes only.
Additional research has to reveal whether or not these
groups are (clinically) different and should be treated
differently.
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